Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Molecular and Clinical Oncology|January 26, 2019
Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case reportNobuki Furubayashi, Takahito Negishi, Tomoharu Uozumi, et al.
Molecular and Clinical Oncology|November 9, 2019
Relapse of aseptic meningitis induced by ipilimumab and nivolumab therapy for metastatic renal cell carcinoma: A case reportDai Takamatsu, Nobuki Furubayashi, Takahito Negishi, et al.
Virchows Archiv : an International Journal of Pathology|May 25, 2020
The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid featuresFumio Kinoshita, Kenichi Kohashi, Masaaki Sugimoto, et al.
Oncology Letters|April 8, 2020
Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinomaNobuki Furubayashi, Takahito Negishi, Dai Takamatsu, et al.
Oncology Letters|September 29, 2020
Radiographical efficacy of systemic treatment for bone metastasis from renal cell carcinomaTakahito Negishi, Nobuki Furubayashi, Dai Takamatsu, et al.
Pathology, Research and Practice|March 29, 2023
Prognostic impact of CD73/adenosine 2A receptor (A2AR) in renal cell carcinoma and immune microenvironmental status with sarcomatoid changes and rhabdoid featuresDai Takamatsu, Daisuke Kiyozawa, Kenichi Kohashi, et al.
Genes, Chromosomes & Cancer|August 7, 2025
Comprehensive mRNA Expressional Analysis of SMARCB1-Deficient Renal Cell Carcinoma in Patients Without HemoglobinopathiesDaisuke Kiyozawa, Genshiro Fukuchi, Takumi Miyamoto, et al.
Pathology, Research and Practice|January 20, 2023
TFE3-immunopositive papillary renal cell carcinoma: A clinicopathological, immunohistochemical, and genetic studyDai Takamatsu, Kenichi Kohashi, Daisuke Kiyozawa, et al.
International Cancer Conference Journal|March 10, 2023
Interstitial pneumonia after regression by olaparib for neuroendocrine prostate cancer with <i>BRCA1</i> mutation: a case reportMasashi Kaitsumaru, Masaki Shiota, Dai Takamatsu, et al.
Human Pathology|May 4, 2020
Programmed death ligand 1/indoleamine 2,3-dioxygenase 1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid featuresDaisuke Kiyozawa, Dai Takamatsu, Kenichi Kohashi, et al.
Pageof 4